AU Stock MarketDetailed Quotes

MAP Microba Life Sciences Ltd

Watchlist
  • 0.200
  • +0.005+2.56%
20min DelayMarket Closed Jul 26 16:00 AET
89.57MMarket Cap-5263P/E (Static)

Microba Life Sciences Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
22.73%9.09M
7.41M
Revenue from customers
37.89%6.36M
--4.61M
Income from government grants
-2.39%2.73M
--2.8M
Other cash income from operating activities
--3.08K
----
Cash paid
-24.56%-22.22M
-17.84M
Payments to suppliers for goods and services
-24.56%-22.22M
---17.84M
Direct interest paid
-9.27%-60.41K
---55.29K
Direct interest received
1,513.65%799.58K
--49.55K
Direct tax refund paid
97.57%-224
---9.23K
Operating cash flow
-18.61%-12.39M
---10.45M
Investing cash flow
Cash flow from continuing investing activities
-73.11%-3M
-1.73M
Net PPE purchase and sale
66.17%-550.46K
---1.63M
Net intangibles purchas and sale
-950.44%-2.49M
---236.7K
Net investment purchase and sale
----
---154.13K
Net other investing changes
-86.67%38.09K
--285.79K
Cash from discontinued investing activities
Investing cash flow
-73.11%-3M
---1.73M
Financing cash flow
Cash flow from continuing financing activities
-42.89%16.68M
29.22M
Net issuance payments of debt
-102.65%-5.34K
--201.59K
Net common stock issuance
-41.26%17.24M
--29.35M
Net other financing activities
-65.59%-547.84K
---330.84K
Cash from discontinued financing activities
Financing cash flow
-42.89%16.68M
--29.22M
Net cash flow
Beginning cash position
135.62%30.58M
--12.98M
Current changes in cash
-92.42%1.29M
--17.03M
Effect of exchange rate changes
-69.80%171.36K
--567.43K
End cash Position
4.78%32.04M
--30.58M
Free cash from
-25.23%-15.43M
---12.32M
Accounting Standards
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 22.73%9.09M7.41M
Revenue from customers 37.89%6.36M--4.61M
Income from government grants -2.39%2.73M--2.8M
Other cash income from operating activities --3.08K----
Cash paid -24.56%-22.22M-17.84M
Payments to suppliers for goods and services -24.56%-22.22M---17.84M
Direct interest paid -9.27%-60.41K---55.29K
Direct interest received 1,513.65%799.58K--49.55K
Direct tax refund paid 97.57%-224---9.23K
Operating cash flow -18.61%-12.39M---10.45M
Investing cash flow
Cash flow from continuing investing activities -73.11%-3M-1.73M
Net PPE purchase and sale 66.17%-550.46K---1.63M
Net intangibles purchas and sale -950.44%-2.49M---236.7K
Net investment purchase and sale -------154.13K
Net other investing changes -86.67%38.09K--285.79K
Cash from discontinued investing activities
Investing cash flow -73.11%-3M---1.73M
Financing cash flow
Cash flow from continuing financing activities -42.89%16.68M29.22M
Net issuance payments of debt -102.65%-5.34K--201.59K
Net common stock issuance -41.26%17.24M--29.35M
Net other financing activities -65.59%-547.84K---330.84K
Cash from discontinued financing activities
Financing cash flow -42.89%16.68M--29.22M
Net cash flow
Beginning cash position 135.62%30.58M--12.98M
Current changes in cash -92.42%1.29M--17.03M
Effect of exchange rate changes -69.80%171.36K--567.43K
End cash Position 4.78%32.04M--30.58M
Free cash from -25.23%-15.43M---12.32M
Accounting Standards US-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg